Mebutamate

From Wikipedia, the free encyclopedia

Mebutamate
Systematic (IUPAC) name
2-sec-butyl-2-methylpropane-1,3-diyl dicarbamate
Identifiers
CAS number	64-55-1
ATC code	N05BC04
PubChem	6151
Chemical data
Formula	C10H20N2O4
Mol. mass	232.277 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

Mebutamate is a sedative and anxiolytic drug with anti-hypertensive (blood pressure lowering) effects. It has effects comparable to those of barbiturates such as secobarbital, but is only around 1/3rd the potency of secobarbital as a sedative. Side effects include dizziness and headaches.^[1]

[edit] References

1. ^ Tetreault L, Richer P, Bordeleau JM. Hypnotic properties of mebutamate: a comparative study of mebutamate, secobarbital and placebo in psychiatric patients. Canadian Medical Association Journal. 1967 Aug 19;97(8):395-8.

• The Merck Index, 12th Edition. 5813

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.